RxDoctor Payments DataLook up a doctor →

Curuchi Anand

Gastroenterology · Worcester, MANPI 1336111731

Payments from drug & device makers

$117,372in general payments, 2019–2025

Across 612 payments — averaging $191.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$108K
  • Lilly USA, LLC$1K
  • Johnson & Johnson$728
  • Gilead$726
  • AstraZeneca$468
  • Pfizer$450
  • plus $6K from 51 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)211$108,409
Lilly USA, LLC45$1,041
Johnson & Johnson(2 entities)27$728
Gilead29$726
AstraZeneca22$468
Pfizer19$450
Amgen18$395
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC17$388
GSK18$382
Merck20$358
Alnylam Pharmaceuticals Inc.12$309
Phathom Pharmaceuticals, Inc.14$309
Inspire Medical Systems, Inc.20$294
Kiniksa Pharmaceuticals International, PLC10$246
Novo Nordisk10$242
Abiomed7$202
Takeda Pharmaceuticals U.S.A., Inc.11$163
Braintree Laboratories, Inc.12$158
QOL Medical, LLC4$154
Exact Sciences5$131
Novartis7$122
Bridgebio Pharma, Inc.4$110
Bayer5$105
Viiv Healthcare Company4$104
Boehringer Ingelheim5$102
Nestle Healthcare Nutrition Inc.4$97
Redhill Biopharma Inc.3$76
Actelion Pharmaceuticals US, Inc.2$71
E.r. Squibb & Sons, L.L.C.3$69
Daiichi Sankyo Inc.3$62
Vertex2$59
Amarin Pharma, Inc.3$57
Astellas Pharma US Inc2$55
Sumitomo Pharma America, Inc.2$55
Dexcom, Inc.2$50
Abbott2$45
Alcresta Therapeutics, Inc.2$44
Eisai Inc.2$43
Seqirus USA Inc2$40
Ardelyx, Inc.2$40
Kiniksa Pharmaceuticals, Ltd.2$37
Esperion Therapeutics, Inc.2$35
Agios Pharmaceuticals, Inc.1$30
Otsuka America Pharmaceutical, Inc.1$30
Theratechnologies Inc.1$29
Sanofi Pasteur Inc.2$28
Madrigal Pharmaceuticals1$28
Baxter Healthcare1$28
Antares Pharma, Inc.1$23
Valneva USA, Inc.1$23
Idorsia Pharmaceuticals US Inc1$20
Paratek Pharmaceuticals, Inc.1$20
Regeneron Healthcare Solutions, Inc.1$20
Aimmune Therapeutics, Inc.1$18
Kowa Pharmaceuticals America, Inc.1$16
Biohaven Pharmaceutical Holding Company Ltd.1$15
Ferring Pharmaceuticals Inc.1$12

How this compares

$117,372 in reported general payments places this provider in the 90th percentile of 579 gastroenterology providers in Massachusetts.

See all gastroenterology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$121,528
Medicare patients
631
Services billed
1,199

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Worcester

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →